Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/108766

In Collections

This item can be found in the following collections:

Tsakiris, D.J.; Stel, V.S.; Finne, P.; Fraser, E.; Heaf, J.; Meester, J. de; ... ; Jager, K.J. (2010)

Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study

Article / Letter to editor
Background. Information on demographics and survival of patients starting renal replacement therapy (RRT) for end-stage renal disease (ESRD) due to multiple myeloma (MM) or light-chain deposit disease (LCDD) is scarce. The aim of this study was to describe the incidence, characteristics, causes of death and survival rates of RRT for ESRD due to MM or LCDD in the ERA-EDTA Registry. Methods. Thirteen national registries providing data on patients who started RRT from 1986-2005 to the ERA-EDTA Registry participated. Incidence per million population (pmp) of RRT for ESRD due to MM or LCDD and other causes (non-MM) was observed overtime. Patient survival on RRT was examined, unadjusted and adjusted for age and gender. Results. Of the 159 637 patients on RRT, 2453 (1.54%) had MM or LCDD. The incidence of RRT for ESRD due to MM or LCDD, adjusted for age and gender, increased from 0.70 pmp in 1986-1990 to 2.52 pmp in 2001-2005. MM and LCDD patients compared to non-MM patients were older and...Show moreBackground. Information on demographics and survival of patients starting renal replacement therapy (RRT) for end-stage renal disease (ESRD) due to multiple myeloma (MM) or light-chain deposit disease (LCDD) is scarce. The aim of this study was to describe the incidence, characteristics, causes of death and survival rates of RRT for ESRD due to MM or LCDD in the ERA-EDTA Registry. Methods. Thirteen national registries providing data on patients who started RRT from 1986-2005 to the ERA-EDTA Registry participated. Incidence per million population (pmp) of RRT for ESRD due to MM or LCDD and other causes (non-MM) was observed overtime. Patient survival on RRT was examined, unadjusted and adjusted for age and gender. Results. Of the 159 637 patients on RRT, 2453 (1.54%) had MM or LCDD. The incidence of RRT for ESRD due to MM or LCDD, adjusted for age and gender, increased from 0.70 pmp in 1986-1990 to 2.52 pmp in 2001-2005. MM and LCDD patients compared to non-MM patients were older and a higher percentage was on haemodialysis at day 91 after the start of RRT. The most common causes of death in MM and LCDD patients were malignancy (36.1%), cardiovascular causes (17.2%) and infection (14.7%). MM and LCDD patients had a 2.77 (95% CI, 2.65-2.90) higher risk of death compared to non-MM patients. The unadjusted median survival on RRT was 0.91 years in MM and LCDD patients and 4.46 years in nonMM patients. During follow-up, 35 patients were transplanted and their mean survival was 9.6 years. Conclusion. The incidence of RRT for ESR.D due to MM or LCDD has increased over the past 20 years in Europe. The median patient survival on RRT for MM and LCDD patientsShow less
haemodialysis incidence multiple myeloma light-chain deposit disease peritoneal dialysis survival transplantation peritoneal-dialysis failure hemodialysis
All authors
Tsakiris, D.J.; Stel, V.S.; Finne, P.; Fraser, E.; Heaf, J.; Meester, J. de; Schmaldienst, S.; Dekker, F.; Verrina, E.; Jager, K.J.
Date
2010-04-30
Journal
Nephrology Dialysis Transplantation
Volume
25
Issue
4
Pages
1200 - 1206
DOI
doi:10.1093/ndt/gfp679